首页 > 市场调查报告书 > 製药

生物製剂基因治疗学和RNAi 以基因为基之药物开发

市场调查报告书

商品编码

1510409

细胞凋亡检测市场规模、份额和成长分析：按产品类型、检测技术、应用、最终用户、地区 - 产业预测，2024-2031

Apoptosis Assay Market Size, Share, Growth Analysis, By Product Type(Instruments, Assay Kits ), By Detection Technology, By Application, By End-User, By Region - Industry Forecast 2024-2031

出版日期: 2024年07月03日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年细胞凋亡检测市场规模预估为53.4亿美元，预测期间（2024-2031年）复合年增长率为10.5%，从2023年的59亿美元增加至2031年的131.2亿美元，预计还会增长。

细胞凋亡检测透过促进细胞凋亡机制的研究并评估其对疾病进展和治疗的影响，在生物医学研究、药物发现和临床诊断中发挥重要作用。这些检测和测量与细胞凋亡相关的各种生化和细胞事件，包括 DNA 断裂、丝胺酸外化、半胱天冬酶活化、粒线体膜电位变化和细胞色素 c 释放。由于多种因素，全球细胞凋亡检测市场近年来显着成长。首先，癌症、神经退化性疾病和心血管疾病等慢性疾病的盛行率不断增加，越来越多地使用细胞凋亡检测来探讨其潜在机制。此外，向个人化医疗和标靶治疗的转变增加了对准确有效的细胞凋亡检测的需求，以评估药物疗效并指导治疗决策。技术进步也发挥着重要作用，创新的检测平台提高了灵敏度、特异性和通量。例如，流式细胞技术、萤光显微镜和高内涵筛检系统等技术允许在单细胞层级同时分析多个细胞凋亡参数，从而彻底改变了细胞凋亡研究。总之，全球细胞凋亡检测市场对于增进我们对程序性细胞死亡及其对疾病病理和治疗策略的影响的理解至关重要。随着持续的研究、技术创新和个人化医疗方法的不断采用，市场有望持续成长，并为全球研究人员、临床医生和製药公司提供必要的工具和见解。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Promega Corporation（United States）
Thermo Fisher Scientific Inc.（United States）
Bio-Rad Laboratories, Inc.（United States）
Merck KGaA（Germany）
PerkinElmer, Inc.（United States）
Abcam plc（United Kingdom）
Cell Signaling Technology, Inc.（United States）
BD Biosciences（United States）
GenScript Biotech Corporation（China）
Bio-Techne Corporation（United States）
Sartorius AG（Germany）
Beckman Coulter, Inc.（United States）
Enzo Biochem, Inc.（United States）
Lonza Group Ltd.（Switzerland）
Biotium, Inc.（United States）
Trevigen, Inc.（United States）
Essen Bioscience（United States）
Cayman Chemical Company（United States）
Abnova Corporation（Taiwan）
NanoString Technologies, Inc.（United States）

简介目录

Product Code: SQMIG35I2299

Apoptosis Assays Market size was valued at USD 5.34 billion in 2022 and is poised to grow from USD 5.90 billion in 2023 to USD 13.12 billion by 2031, at a CAGR of 10.5% during the forecast period (2024-2031).

Apoptosis assays play a crucial role in biomedical research, drug discovery, and clinical diagnostics by facilitating the study of apoptosis mechanisms and assessing their impact on disease progression and treatments. These assays enable the detection and measurement of various biochemical and cellular events associated with apoptosis, such as DNA fragmentation, phosphatidylserine externalization, caspase activation, changes in mitochondrial membrane potential, and release of cytochrome c. They provide researchers and clinicians with valuable insights into cell death pathways, helping to evaluate therapeutic agents and identify potential drug targets. The global market for apoptosis assays has seen substantial growth recently driven by several factors. Firstly, there is a growing prevalence of chronic diseases like cancer, neurodegenerative disorders, and cardiovascular diseases, prompting increased use of apoptosis assays to explore their underlying mechanisms. Additionally, the shift towards personalized medicine and targeted therapies has heightened the demand for accurate and efficient apoptosis assays to assess drug efficacy and guide treatment decisions. Technological advancements have also played a pivotal role, with innovative assay platforms offering enhanced sensitivity, specificity, and throughput. For instance, technologies such as flow cytometry, fluorescence microscopy, and high-content screening systems have revolutionized apoptosis research by enabling simultaneous analysis of multiple apoptotic parameters at the single-cell level. In conclusion, the global apoptosis assays market is pivotal in advancing our understanding of programmed cell death and its implications in disease pathology and therapeutic strategies. With ongoing research, technological innovations, and increasing adoption of personalized medicine approaches, the market is poised for continued growth, providing indispensable tools and insights to researchers, clinicians, and pharmaceutical companies worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Apoptosis Assays market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Apoptosis Assays Market Segmental Analysis

The global apoptosis assays market is segmented based on product type, detection technology, application, end-user, and region. By product, the market is segmented into Instruments, Assay Kits (Caspase Assays, Annexin V and Cell Permeability Assays, DNA Fragmentation Assays, Mitochondrial Assays), Reagents, Microplates. Based on Detection Technology, the market is segmented into Flow Cytometry, Cell Imaging and Microscopy, Spectrophotometry, and Others. By Application, the market is segmented into Drug Discovery and Development, Clinical and Diagnostic Applications, Basic Research, Stem Cell Research. By end-user, the market is segmented into pharmaceutical & biotechnology companies, hospital & diagnostic laboratories, and academic & research institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

Drivers of the Apoptosis Assays Market

The global market is expected to see substantial growth due to significant investments by industry players in developing advanced and cost-effective assay kits, alongside increasing demand from users for apoptosis assay kits. Reagents play a critical role in apoptosis testing methods, prompting numerous kit manufacturers to introduce a variety of products incorporating innovative reagents that improve the detection and monitoring of cell death. This trend is expected to drive growth in the apoptosis assays market in the forecasted period.

Restraints in the Apoptosis Assays Market

There is a shortage of skilled personnel for apoptosis assay research and development. Cells can undergo apoptosis or necrosis, with necrosis typically involving cell swelling and rupture following acute injury, which can hinder the market's growth rate.

Market Trends of the Apoptosis Assays Market

There is a growing emphasis on personalized medicine within the healthcare sector, driving the demand for precise apoptosis assays. These assays are essential for assessing drug effectiveness, pinpointing therapy targets, and making treatment choices tailored to individual patient profiles. Concurrently, partnerships and collaborations between major industry stakeholders, academic institutions, and research bodies are increasingly prevalent. These alliances pool expertise and resources to accelerate technological advancements in apoptosis assays, foster innovation, and broaden market reach.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Patent Analysis
Value Chain Analysis
Ecosystem of the Market
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Apoptosis assays Market by Product Type

Market Overview
Assay Kits
- Caspase Assays
- Annexin V and Cell Permeability Assays
- DNA Fragmentation Assays
- Mitochondrial Assays
Instruments
Reagents
Microplates

Apoptosis assays Market by Detection Technology

Market Overview
Flow Cytometry
Cell Imaging and Microscopy
Spectrophotometry
Others

Apoptosis assays Market by Application

Market Overview
Drug Discovery and Development
Clinical and Diagnostic Applications
Basic Research
Stem Cell Research

Apoptosis assays Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
Hospital & Diagnostic Laboratories
Academic & Research Institutes

Apoptosis assays Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Promega Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abcam plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD Biosciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotium, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trevigen, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Essen Bioscience (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cayman Chemical Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abnova Corporation (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoString Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments